Traditional Chinese Medicine Intervention for Ischemic Cerebrovascular Disease and Diabetes Mellitus: An Efficacy Comparative Study
A phase 4 trial registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 3666 participants.
Also called NCT07121088
- Study
- In this atlas
Overview
- Design
- Interventional study; non-randomized; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 3,666 participants
- Registry
-
NCT07121088
-
- Planned start
- (anticipated)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Not reported
- Registry status
- Not yet recruiting
Technical summary
Registry record NCT07121088. Non-randomized; no masking; primary purpose treatment. Start 2025-08-31 (anticipated); primary completion 2026-12-31 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Traditional Chinese Medicine Intervention for Ischemic Cerebrovascular Disease and Diabetes Mellitus: An Efficacy Comparative Study
- Acronym
- TIDES
- Condition
- Ischemic Cerebral Infarction
- Condition
- Diabetes Mellitus
- Intervention (Drug)
- (Intensive treatment) Chuanzhi Tongluo Capsules
- Intervention (Other)
- Standard Treatment (Guideline-Based)
- Intervention (Drug)
- (Sequential treatment) Chuanzhi Tongluo Capsules
- Intervention (Drug)
- TCM Syndrome Differentiation Decoction
- Lead sponsor
- Guangzhou University of Traditional Chinese Medicine
Record details
- Record id
cardio:ct-nct07121088- Content hash
6f0b88e50b85dfbc61a8c9ded5cb3ce57d653aa2a2f8862c2c1181a7f73c7afd